NCT07457775: Liposomal Irinotecan in Combination With Temozolomide and Bevacizumab in Patients With Advanced STS
- State
- Not started
- Phase
- Phase 2
- People
- 24 planned
- Started
- 31 Mar 2026
- Primary completion
- 31 Jan 2028
- Arms
- Irinotecan Hydrochloride Liposome Injection(II) combined with temozolomide and bevacizumab
- Results
- None posted
- 9 Mar 2026: Trial registered